Compare SLQT & FBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SLQT | FBIO |
|---|---|---|
| Founded | 1999 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Specialty Insurers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 132.7M | 111.0M |
| IPO Year | 2020 | 2011 |
| Metric | SLQT | FBIO |
|---|---|---|
| Price | $0.53 | $2.72 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | $2.88 | ★ $17.00 |
| AVG Volume (30 Days) | ★ 1.3M | 542.9K |
| Earning Date | 05-05-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 97.40 |
| EPS | N/A | ★ 2.86 |
| Revenue | ★ $1,618,499,000.00 | $63,262,000.00 |
| Revenue This Year | $10.97 | $55.22 |
| Revenue Next Year | $6.14 | $40.55 |
| P/E Ratio | ★ N/A | $0.95 |
| Revenue Growth | 6.02 | ★ 9.69 |
| 52 Week Low | $0.48 | $2.18 |
| 52 Week High | $2.22 | $4.53 |
| Indicator | SLQT | FBIO |
|---|---|---|
| Relative Strength Index (RSI) | 34.68 | 42.09 |
| Support Level | $0.48 | $2.70 |
| Resistance Level | $0.79 | $2.98 |
| Average True Range (ATR) | 0.06 | 0.12 |
| MACD | -0.02 | -0.00 |
| Stochastic Oscillator | 13.17 | 23.60 |
SelectQuote Inc is a Direct-to-consumer (DTC) distribution platform which facilitates consumers to shop for health, life and auto & home insurance policies online. The company generates its revenues by selling insurance products on behalf of the insurance carrier partners in the form of a commission. It has four reportable segments namely Senior, Healthcare Services, Life, and Auto & Home. It functions through three lines namely, SelectQuote Senior, SelectQuote Life, and SelectQuote Auto & Home.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development.